cas 843666-26-2|| where to buy 1-(1,1-Dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-L-glutamate

Nom du produit:1-(1,1-Dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-L-glutamate

IUPAC Name:1-tert-butyl 2,5-dioxopyrrolidin-1-yl (2R)-2-[16-(tert-butoxy)-16-oxohexadecanamido]pentanedioate

: CAS：843666-26-2; Formule moléculaire：C33H56N2O9; Pureté：99% HPLC

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 843666-26-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:843666-26-2; Formule moléculaire:C33H56N2O9; Point de fusion:-; Code SMILES:CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)ON1C(=O)CCC1=O)C(=O)OC(C)(C)C; Densité:

: Numéro de catalogue:CM1075332; Poids moléculaire:624.82; Point d'ébullition:; N° Mdl:; Stockage:

: Fatty Acid Modified Side Chains; Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.